ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.57
0.23%
US Tech 100
19,289.60
-0.61%
S&P 500
5,473.17
-0.25%
US Dollar vs CAD
1.36885
-0.13%
Bitcoin
64,904.93
-0.10%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Akoya BioSciences Inc (AKYA) Share Price

Akoya BioSciences Inc

Akoya BioSciences Inc (AKYA)

2.23
0.09
(4.21%)
At close: June 20 3:00PM
Delayed by 15 minutes
2.23
-0.01
( -0.45% )
After Hours: 5:56PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.23
Bid
2.15
Ask
2.25
Volume
140,596
2.10 Day's Range 2.24
1.88 52 Week Range 8.31
Market Cap
110.075M
Previous Close
2.14
Open
2.13
Last Trade
4
@
2.15
Last Trade Time
18:02:49
Financial Volume
US$ 303,039
VWAP
2.1554
Average Volume (3m)
329,747
Shares Outstanding
49,140,731
Dividend Yield
-
PE Ratio
-1.74
Earnings Per Share (EPS)
-1.29
Revenue
96.63M
Net Profit
-63.32M

About Akoya BioSciences Inc

Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clini... Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.akoyabio.com
Headquarters
Dover, Delaware, USA
Founded
1970
Akoya BioSciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker AKYA. The last closing price for Akoya BioSciences was US$2.14. Over the last year, Akoya BioSciences shares have traded in a share price range of US$ 1.88 to US$ 8.31.

Akoya BioSciences currently has 49,140,731 shares outstanding. The market capitalization of Akoya BioSciences is US$110.08 million. Akoya BioSciences has a price to earnings ratio (PE ratio) of -1.74.

AKYA Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

June 12 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 11 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 07 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 13 2024
Edgar (US Regulatory)

Akoya Biosciences Reports First Quarter 2024 Financial Results

MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter...

May 13 2024
GlobeNewswire Inc.

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

MARLBOROUGH, Mass. and FRANKFURT, Germany, May 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory...

May 09 2024
GlobeNewswire Inc.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-0.8888888888892.252.272.052668822.15785083CS
4-0.06-2.620087336242.292.471.884204512.11613668CS
12-2.5-52.85412262164.734.791.883297472.80392067CS
26-2.44-52.24839400434.676.311.882603193.80001632CS
52-6.03-73.00242130758.268.311.882077144.31102847CS
156-17-88.403536141419.2321.841.881629128.62249376CS
260-23.77-91.42307692312628.941.881637759.41307825CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GRCGold Springs Resource Corp
$ 0.09
(20.00%)
255.2k
SFDNXT Energy Solutions Inc
$ 0.16
(18.52%)
118k
SAMStarcore International Mines Ltd
$ 0.14
(16.67%)
525
DSVDiscovery Silver Corp
$ 1.03
(13.19%)
913.48k
PYRPyroGenesis Canada Inc
$ 0.69
(13.11%)
191.75k
CFXCanfor Pulp Products Inc
$ 1.04
(-25.71%)
141.77k
AEZSAeterna Zentaris Inc
$ 6.04
(-24.50%)
14.45k
LPENLoop Energy Inc
$ 0.025
(-16.67%)
15.04k
ETEvertz Technologies Ltd
$ 13.30
(-13.30%)
120.44k
AABAberdeen International Inc
$ 0.035
(-12.50%)
1.61M
CNQCanadian Natural Resources Ltd
$ 47.87
(1.36%)
29.03M
TRPTC Energy Corporation
$ 52.25
(-0.08%)
14.09M
SUSuncor Energy Inc
$ 50.82
(0.08%)
8.95M
MFCManulife Financial Corporation
$ 35.23
(0.46%)
7.75M
POWPower Corp of Canada
$ 37.57
(-0.71%)
6.65M

Discussion

View Full Feed
prototype_101 prototype_101 3 minutes ago
PECC October 22-23 Optica Photonic-Enabled Cloud Computing Industry Summit hosted by Synopsis has a TOP SHELF speaker list, check it out here

https://www.optica.org/events/industry_events/2024/pecc/program_speakers/

Investors keep in mind that Synopsis has been posting
LWLG
girlfriend girlfriend 3 minutes ago
Yeah miserable chart.
SOFI
gfp927z gfp927z 4 minutes ago
>>> Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug


Bloomberg

by Gerry Smith

Jun 20, 2024


https://finance.yahoo.com/news/sarepta-jumps-broad-approval-muscular-220459501.html


(Bloomberg) --
jaramill jaramill 4 minutes ago
$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

Link to Minutes --> https://www.otcmarkets.com/otcapi/company/financial-report/405767/content MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

HANNOVER HOUSE, INC.


HHSE
NASDAQ2020 NASDAQ2020 4 minutes ago
https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
theorysuit theorysuit 4 minutes ago
Why would you look back. They need reimbursement to even sell this and no one knows what kind of revenue split they have with advent. There is no path to profitability in the UK. Let the dilution continue for perpetuity. This is a piggy bank/ATM for LP and cronies. ADVENT and annual salari
NWBO
Testpilot Testpilot 4 minutes ago
If there’s going to be a delay, we’ll see a notification early next week that both companies voted to do so.
CRTG
Grip it and Sip It Grip it and Sip It 4 minutes ago
Thanks Closet- sounds worse than I read originally.

The 13% vig is unbelievable. What do you suspect with the price action? I suspect it will hit around $.10 within the week but much depends on whether many longs accept the deal and exercise.

The company will be dumping
CYDY
PioneerDruid532 PioneerDruid532 5 minutes ago
From Jim Sims - In general, we pass on the cost of our copper feedstock to customers, so it is typically a wash, even though it can increase topline revenue. We do benefit from higher copper pricing when we have lower-cost copper in inventory (lead-lag effect) but that can reverse at times.
IAALF
Diamondhands45 Diamondhands45 5 minutes ago
So is being up 1000% with the money and balls to risk and be something.

Not some wannabe cool kid showing up with his chest out and false bravado who got no skin in the game and nothing in his pants
SPZI
jxyzobrien jxyzobrien 5 minutes ago
mri good
jalive jalive 5 minutes ago
Part in which some have a bunch of outstanding shares to make it harder to buy up a bigger %
GTCH
HoldEm777 HoldEm777 5 minutes ago
I looked at the chart again and think I misspoke in my reply to Marc. .0036 breaks its . 003 not .002. If .003 gives up then .0026 then it falls to the gap. I guess they can find support at any level though.
JMHO.
https://investorshub.advfn.com/uimage/uploads/2024/6/20/rslbp5EE03BDD-
RONN
JimmyRich JimmyRich 5 minutes ago
Fellas… as much as it’s interesting to see the back and forth.. I think we just need to remain focused on the goal here and that’s the approval and accomplishing the goal., good luck all
UEEC
mc73 mc73 6 minutes ago
I found a good one, finally. Hope to put some profits into BTC in the next year or so.

Glad to hear your crypto investments are working out.
CVSI
Enterprising Investor Enterprising Investor 6 minutes ago
Here we go again!
TPHS
jaramill jaramill 7 minutes ago
And the forget the dearly departed as of this afternoon.....Donald Sutherland (RIP)
HHSE
Zorax Zorax 7 minutes ago
Pretend judge cannon and the judge on the 11th circuit that is supporting her really really really really really really really really really really really really really really really really really really really really really really really really .......
needs to go.
urge2surge urge2surge 7 minutes ago
So this company has a plan to develop a prototype or two? Is there anything else?
RONN
ClosetInvestor ClosetInvestor 8 minutes ago
Grip - Per the math in the filing, each share is 7.9, which includes 1 warrant, another .2 shares and more than 13% cash to Paulson!

7.9 cents per unit!
CYDY
kabunushi kabunushi 8 minutes ago
Very reasonable approach.

But since you own it, why not own that own it and sit patiently. What do you get out of coming on a MB and whining like a little girl about it? Seriously, when you own something like this, gut it up while you hold it. I can never understand why investors tras
NWBO
marcis marcis 8 minutes ago
Is this Logan’s bro? On CIV&X

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174536983
CGAC
Diamondhands45 Diamondhands45 9 minutes ago
You forgot revenues. Otherwise good summary
SPZI
XenaLives XenaLives 10 minutes ago
Just noise, imo....

[pre]
tim, last, bid, ask, volume

06/20/24 18:04:28 4.01 3.90 4.14 15
06/20/24 17:35:19 4.15 3.90 4.15 1,800
06/20/24 17:25:39 4.1479 3.90 4.15 800
06/20/24 16:37:57 4.15 3.90 4.15 500
06/20/24 16:30:44 3.85 3.82 4.
AVXL
north40000 north40000 10 minutes ago
Keep your eye on insurance coverage and side effects of LLY and NVO meds for weight loss, as well as GILD’s presentation at ADA conference beginning tomorrow, 6/21/2024. I have stayed out of LLY and NVO while enjoying our substantial gain in 7,550 shares of NVDA (mentioned in your WSJ story link; I
LLY NVDA NVO

Your Recent History

NASDAQ
AKYA
Akoya BioSciences
BIT
P1V3Q6
NLBNPIT1V3Q6 20991231 92...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved